Milestone Pharmaceuticals Stock Wilted: Midweek Decline
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
We break down no-load fund options for IRAs and what that means for your purchasing costs. Find transparent choices that keep more of your money invested.
27,130 articlesInvestors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
A potential 18-day walkout by 45,000 Samsung memory workers could disrupt DRAM and high-bandwidth memory supply, send...
European leaders weigh price caps on essentials to curb inflation, a move that has CEOs warning of market distortions...
The United States appears to be nearing a practical ceiling in its sanctions campaign against Iran, raising questions...
Applovin rallied today as traders weighed an upbeat analyst note against a quiet news cycle. This piece breaks down t...
A big investor just bought millions of Grindr shares after the stock plunged. This article breaks down why grindr sto...
A $1,000 stake in Nvidia a decade ago would now command a large payoff, but the ride was anything but smooth. The sto...
The NY Fed reports a rise in food insecurity, with more people going hungry now than during the COVID-19 crisis. The ...
Ford’s stock price down over the past five years has mirrored a broader pivot in the auto sector—from red‑hot EV bets...
California Governor Gavin Newsom alleges political targeting by the DOJ, linking a widening probe to his potential pr...
A leading market analyst argues SpaceX could see a 50% decline in its stock within six months if it goes public, citi...
U.S. markets show dwindling expectations for imminent rate cuts even as corporate cash runs hot. SpaceX, Alphabet, an...